SCFE Longitudinal International Prospective Registry

NCT ID: NCT04117841

Last Updated: 2024-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-30

Study Completion Date

2028-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Slipped Capital Femoral Epiphysis (SCFE) is the most common disorder of the adolescent hip and diagnosis and treatment of SCFE remain areas of controversy and investigation. The current issues relating to diagnosis stem from an inability to diagnose the condition early on, resulting in increased morbidity. Once diagnosed, there are multiple different options for surgical treatment, including in-situ pinning, and the Modified Dunn procedure. Research is ongoing to determine the parameters that should be considered when selecting a procedure to ensure an ideal outcome. In particular, there is a focus on investigating which treatment method may result in lower incidence of avascular necrosis of the femoral head and femoroacetabular impingement (FAI), two significant long term concerns associated with SCFE. Despite myriad published studies on SCFE, very few are prospective and most lack sufficient patient numbers for clinically meaningful comparative analysis. The aim of this study is to develop a multi-center, international prospective registry of patients with SCFE to facilitate the comprehensive examination of clinical, functional and radiographic outcomes of each treatment, in relation to specific parameters determined prior to intervention. The general registry will serve as a hypothesis-generating database of prospectively collected outcomes. In turn, this will facilitate the development of targeted, hypothesis-testing randomized controlled trials and observational studies that can be housed within the larger registry.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Slipped Capital Femoral Epiphyses SCFE

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I: Prospective from diagnosis

Patients have been enrolled and followed since diagnosis will be placed into Arm I.

Observational

Intervention Type OTHER

All groups will undergo observational data collection. No interventions will be made to patient care.

Arm II: Prior treatment at centre

Patients who have received previous treatment and will continue to receive treatment at the participating center will be placed into Arm II.

Observational

Intervention Type OTHER

All groups will undergo observational data collection. No interventions will be made to patient care.

Arm III: Prior treatment at outside centre

Patients who have received previous treatment at an outside center but are continuing treatment at a participating center will be placed into Arm III.

Observational

Intervention Type OTHER

All groups will undergo observational data collection. No interventions will be made to patient care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational

All groups will undergo observational data collection. No interventions will be made to patient care.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed diagnosis of SCFE
* Intend to receiving follow-up at participating centre
* Less than 18 years old at time of admission
* Adequate diagnostic information and radiographic imaging (for patients previously treated for SCFE)

Exclusion Criteria

* No definitive diagnosis of SCFE
* Do not intend to receive follow-up at a participating centre
* Greater than 18 years old at time of admission
* Prior treatment for SCFE not appropriately documented
* Known or suspected underlying conditions (e.g., cerebral palsy, spina bifida, or osteogenesis imperfecta)
Minimum Eligible Age

0 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of British Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kishore Mulpuri

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kishore Mulpuri, FRCSC

Role: PRINCIPAL_INVESTIGATOR

Principal Investigator

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

British Columbia Children's Hospital

Vancouver, British Columbia, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kishore Mulpuri, FRCSC

Role: CONTACT

(604) 875-2054

Ashley L Munoz, BSc

Role: CONTACT

(604) 875-2359

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emily K Schaeffer, PhD

Role: primary

6048752359

Ashley L Munoz, BSc

Role: backup

6048752359

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H15-03132

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Children Born With Club Feet
NCT03671863 COMPLETED